TET2 binding to enhancers facilitates transcription factor recruitment in hematopoietic cells
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
TET2 binding to enhancers facilitates transcription factor recruitment in hematopoietic cells. / Rasmussen, Kasper D; Berest, Ivan; Kessler, Sandra; Nishimura, Koutarou; Simon-Carrasco, Lucia; Vassiliou, George S; Pedersen, Marianne Terndrup; Christensen, Jesper; Zaugg, Judith; Helin, Kristian.
I: Genome Research, Bind 29, Nr. 4, 2019, s. 564-575.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - TET2 binding to enhancers facilitates transcription factor recruitment in hematopoietic cells
AU - Rasmussen, Kasper D
AU - Berest, Ivan
AU - Kessler, Sandra
AU - Nishimura, Koutarou
AU - Simon-Carrasco, Lucia
AU - Vassiliou, George S
AU - Pedersen, Marianne Terndrup
AU - Christensen, Jesper
AU - Zaugg, Judith
AU - Helin, Kristian
N1 - Published by Cold Spring Harbor Laboratory Press.
PY - 2019
Y1 - 2019
N2 - The epigenetic regulator TET2 is frequently mutated in hematological diseases. Mutations have been shown to arise in hematopoietic stem cells early in disease development, lead to altered DNA methylation landscapes and to an increased risk of hematopoietic malignancy. Here, we show by genome-wide mapping of TET2 binding sites in different cell types that TET2 localizes to regions of open chromatin and cell-type specific enhancers. We find that deletion of Tet2 in native hematopoiesis as well as fully transformed Acute Myeloid Leukemia (AML) results in changes in transcription factor (TF) activity within these regions, and we provide evidence that loss of TET2 leads to attenuation of chromatin binding of members of the basic helix-loop-helix (bHLH) TF family. Together, these findings demonstrate that TET2 activity shapes the local chromatin environment at enhancers to facilitate TF binding and provide a compelling example of how epigenetic dysregulation can affect gene expression patterns and drive disease development.
AB - The epigenetic regulator TET2 is frequently mutated in hematological diseases. Mutations have been shown to arise in hematopoietic stem cells early in disease development, lead to altered DNA methylation landscapes and to an increased risk of hematopoietic malignancy. Here, we show by genome-wide mapping of TET2 binding sites in different cell types that TET2 localizes to regions of open chromatin and cell-type specific enhancers. We find that deletion of Tet2 in native hematopoiesis as well as fully transformed Acute Myeloid Leukemia (AML) results in changes in transcription factor (TF) activity within these regions, and we provide evidence that loss of TET2 leads to attenuation of chromatin binding of members of the basic helix-loop-helix (bHLH) TF family. Together, these findings demonstrate that TET2 activity shapes the local chromatin environment at enhancers to facilitate TF binding and provide a compelling example of how epigenetic dysregulation can affect gene expression patterns and drive disease development.
U2 - 10.1101/gr.239277.118
DO - 10.1101/gr.239277.118
M3 - Journal article
C2 - 30796038
VL - 29
SP - 564
EP - 575
JO - Genome Research
JF - Genome Research
SN - 1088-9051
IS - 4
ER -
ID: 213923731